Common TitleASPIRE
Official Title Simeprevir Increases Rate of Sustained Virologic Response Among Treatment-Experienced Patients with HCV Genotype-1 Infection: A Phase IIb Trial
Phase Phase II
ClinicalTrials.gov NCT00980330
Treatments
Simeprevir
Simeprevir
Tradename:OlysioOther Names:SMVClass:DiscontinuedFunding
IndustryTibotec Pharmaceuticals, Ireland